#None #Cardinal Health #Kendall SCD #VTE Prevention

Cardinal Health Launches Innovative Solution for VTE Prevention

In a significant move for healthcare, Cardinal Health has announced the international debut of its Kendall SCD SmartFlow™ Compression System. This cutting-edge technology aims to enhance the prevention of venous thromboembolism (VTE) incidents, particularly deep vein thrombosis and pulmonary embolism. The new system is set to be a game-changer for clinicians and patients alike.

Advancements in Compression Therapy

The Kendall SCD SmartFlow™ is an advancement from the trusted Kendall™ Compression Series, boasting sophisticated features designed to improve patient outcomes. With clinical validation, the system delivers customized intermittent pneumatic compression (IPC) to enhance blood flow in patients at risk for VTE. According to Frederic LeRoy, VP of International Marketing, this system ensures reliable compression therapy while addressing venous stasis symptoms that affect patients suffering from compromised blood flow.

Cutting-Edge Technology Enhancements

One of the standout features of the Kendall SCD SmartFlow™ is its incorporation of Vascular Refill Detection (VRD) technology. This innovative approach allows for a tailored compression cycle that adapts based on an individual’s unique vascular refill time, thus optimizing the number of compression cycles a patient receives over a designated period. This adaptability is crucial in preventing conditions that lead to venous stasis by promoting enhanced blood circulation.

The product's circumferential sleeve design plays a pivotal role in its efficacy. It ensures that therapy can be applied effectively, irrespective of sleeve and tubing positioning, enhancing usability during treatment. The gradient pressure pattern employed by the system maximizes blood flow, thus improving overall treatment outcomes.

Safety and Compliance Features

In addition to its core features, the Kendall SCD SmartFlow™ is equipped with proprietary Patient Sensing™ Technology. This feature actively recognizes whether compression therapy is being properly applied, issuing alerts when it detects that the system is not in correct use. Moreover, the new Therapy Tracker feature meticulously records the duration of therapy, aiding hospitals in maintaining compliance with healthcare regulations and improving patient safety.

A Thoughtful Approach to Healthcare

Shawn McBride, Regional President for EMEA, commented on the system's release, stating, “For over four decades, the Kendall SCD™ compression portfolio has been a trusted choice for healthcare professionals across Europe, helping protect patients from venous thromboembolism (VTE). This newly redesigned system reflects our ongoing commitment to innovation within the Kendall™ line and builds on our long-standing expertise in compression therapy.”

Market Availability

Currently, the Cardinal Health™ Kendall SCD SmartFlow™ Compression System is being introduced in Europe, with plans for gradual expansion into markets across Australia, New Zealand, Brazil, Korea, and more regions in the Middle East, Africa, Asia, and Latin America. This rollout makes it accessible to a broad audience, significantly enhancing preventative care options for healthcare facilities worldwide.

Conclusion

The launch of the Kendall SCD SmartFlow™ Compression System marks a pivotal advancement in the fight against conditions like deep vein thrombosis and pulmonary embolism. By harnessing advanced technologies and focusing on patient-centric design, Cardinal Health reaffirms its dedication to improving healthcare outcomes and patient safety on a global scale. To learn more about this innovative product, visit the official Cardinal Health website.